What Is the Difference Between Breztri and Trelegy? COPD Comparison Guide

If you or someone you know has COPD, your doctor may prescribe triple-therapy inhalers such as Breztri Aerosphere or Trelegy Ellipta. These are commonly used long-term maintenance inhalers that help control symptoms and reduce flare-ups.

Although both inhalers work in similar ways, there are important differences in dosing schedule, inhaler design, approved uses, and convenience that may influence which option is best. Breztri is approved by the U.S. Food and Drug Administration (FDA) only for COPD, while Trelegy is approved for both COPD and asthma in adults. Choosing between them usually depends on your symptoms, inhaler technique, and daily routine.

Breztri vs. Trelegy: Quick Important Details

To understand how these two inhalers differ in practice, it is helpful to compare their dosing, delivery method, and approved uses side by side.

What Type of Medications Are in Breztri and Trelegy?

Both Breztri and Trelegy are known as triple-therapy inhalers because they contain three types of medications:

• Inhaled corticosteroid (ICS): Reduces airway inflammation
• Long-acting beta-agonist (LABA): Helps relax airway muscles
• Long-acting muscarinic antagonist (LAMA): Keeps airways open for longer periods

Breztri vs. Trelegy for COPD: Which Works Better?

Both inhalers are effective for COPD management, but Trelegy Ellipta is more commonly preferred in clinical practice due to once-daily dosing and broader FDA approval for both COPD and asthma, while Breztri Aerosphere may be preferred for patients who tolerate MDI spray inhalers better or have difficulty generating the strong inhalation flow required for dry powder inhalers.

Clinical studies, including large randomized trials and real-world observational data published in respiratory medicine journals, show that both Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) and Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) improve lung function (FEV1), reduce moderate-to-severe COPD exacerbations, and improve symptom control over time.

Doctors typically decide between these medications based on:

• Symptom severity
• Patient inhaler technique
• Dosing preference
• Insurance coverage
• Side effect history

When Breztri Aerosphere may be preferred:

• COPD patients who struggle with dry powder inhalers
• Those who prefer metered-dose spray delivery
• Patients who cannot take deep, forceful inhalation

When Trelegy Ellipta may be preferred:

• Patients who want once-daily dosing convenience
• Individuals with both COPD and asthma
• Those comfortable using dry powder inhalers

Clinicians typically choose between these inhalers based on symptom severity, inhaler technique, patient preference, and insurance coverage, rather than one being universally “better” than the other.

Breztri vs. Trelegy Side Effects

Since both medications belong to the same triple-therapy class, their side effect profiles are similar, but there are a few clinically relevant differences worth noting.

Common Side Effects

These common side effects may occur while taking either medication:

• Upper respiratory infections
• Back pain
• Headache
• Oral thrush
• Pneumonia
• Voice changes

Since both inhalers contain corticosteroids, patients are usually advised to rinse their mouths after use to reduce the risk of fungal infections.

Serious Side Effects (seek medical help)

They may be uncommon, but seek immediate medical help if they occur:

• Pneumonia
• Increased heart rate
• Bone thinning
• Eye problems such as glaucoma
• Adrenal suppression
• Worsening breathing

Important: Neither Breztri nor Trelegy should be used as a rescue inhaler during sudden breathing attacks. Patients should always keep a fast-acting rescue inhaler available if prescribed.

Switching From Trelegy to Breztri: What to Know

A healthcare provider may recommend switching from one inhaler to another if:

• COPD symptoms worsen
• Side effects become difficult to tolerate
• Frequent flare-ups occur
• Inhaler technique is challenging
• Insurance coverage changes

You should call your healthcare provider if:

• Breathing symptoms are worsening
• You experience frequent flare-ups
• You struggle to use your inhaler correctly
• Side effects become difficult to manage
• You miss doses frequently

Who Should Use Breztri vs. Trelegy?

The right inhaler depends on individual health needs.

Breztri May Be Recommended For:

• Moderate-to-severe COPD
• Patients who struggle with dry powder inhalers
• Those needing spray-based delivery

Trelegy May Be Recommended For:

• COPD patients who prefer once-daily dosing
• Patients with asthma and COPD
• Individuals with strong inhalation ability

Who Should Not Use Breztri vs. Trelegy?

Breztri and Trelegy are widely used for COPD management, though they may not be suitable for everyone.

People Who Should Avoid Breztri or Trelegy Without Medical Approval

These medications may not be appropriate for individuals who:

• Have a severe allergy to any of the ingredients in Breztri or Trelegy.
• Are experiencing a sudden COPD flare-up or asthma attack, as these inhalers are not rescue medications.
• Have a history of severe hypersensitivity reactions to inhaled corticosteroids.
• Are children or adolescents, unless specifically prescribed by a specialist.

The Final Words: Breztri vs. Trelegy

Overall, both Breztri Aerosphere and Trelegy Ellipta are effective long-term COPD maintenance inhalers, but the best option depends on individual patient needs. Trelegy is often favored for its simplicity and broader indications, while Breztri may suit patients who prefer a metered-dose inhaler or have difficulty with dry-powder inhalation. Always consult a healthcare provider before starting or switching treatment.